Presentation (CTI)

OBJECTIVES: Health Technology Assessment (HTA) is a critical tool for decision-making, as it systematically generates clinical and economic evidence to support recommendations on the incorporation and reimbursement of new technologies, helping to optimize the use of available resources. To assess the alignment between CONITEC’s technology incorporations and actual health needs and demands
METHODS: This study analyzed total healthcare expenditures and deaths in Brazil from 2020 to 2024, comparing them to the technologies incorporated during the same period. Health expenditures were grouped by ICD-10 chapters.
RESULTS: • Chapter IX: Diseases of the circulatory system - BRL 18 billion • Chapter I: Certain infectious and parasitic diseases - BRL 17 billion • Chapter II: Neoplasms - BRL 10 billion • Chapter XIX: Injury, poisoning and certain other consequences of external causes - BRL 9 billion • Chapters X and XI: Diseases of the respiratory and digestive systems - BRL 7 billion each These chapters also accounted for the highest mortality rates and absolute number of deaths. However, of the 193 technologies incorporated by CONITEC during the period: • 47 (24.7%) were for the treatment of neoplasms • 35 (18.1%) for infectious and parasitic diseases • 24 (12.4%) for endocrine, nutritional, and metabolic diseases • 14 (7.3%) for digestive system diseases • 12 (6.2%) for circulatory system diseases
CONCLUSIONS: These findings suggest a potential misalignment between the areas of highest healthcare burden and the technologies incorporated by CONITEC, which can increase the health inequalities in the country.